Sickle cell disease: a review

PL Kavanagh, TA Fasipe, T Wun - Jama, 2022 - jamanetwork.com
Importance Sickle cell disease (SCD) is an inherited disorder of hemoglobin, characterized
by formation of long chains of hemoglobin when deoxygenated within capillary beds …

Hydroxyurea (hydroxycarbamide) for sickle cell disease

SJ Nevitt, AP Jones, J Howard - Cochrane Database of …, 2017 - cochranelibrary.com
Background Sickle cell disease (SCD) is one of the most common inherited diseases
worldwide. It is associated with lifelong morbidity and a reduced life expectancy …

Trends in sickle cell disease–related mortality in the United States, 1979 to 2017

AB Payne, JM Mehal, C Chapman, DL Haberling… - Annals of emergency …, 2020 - Elsevier
Study objective We provide an updated assessment of trends in sickle cell disease (SCD)–
related mortality, a significant source of mortality in the United States among black persons …

American Society of Hematology 2021 guidelines for sickle cell disease: stem cell transplantation

J Kanter, RI Liem, F Bernaudin… - Blood …, 2021 - ashpublications.org
Background: Sickle cell disease (SCD) is a life-limiting inherited hemoglobinopathy that
results in significant complications and affects quality of life. Hematopoietic stem cell …

A critical review of sickle cell disease burden and challenges in sub-Saharan Africa

OP Adigwe, SO Onoja, G Onavbavba - Journal of Blood Medicine, 2023 - Taylor & Francis
Sickle cell disease is caused by an abnormality of the β-globin gene and is characterised by
sickling of the red blood cells. Globally, sub-Saharan African countries share the highest …

Sickle cell disease: Reducing the global disease burden

J Mburu, I Odame - International journal of laboratory …, 2019 - Wiley Online Library
Sickle cell disease has been largely an invisible global health issue, especially in regions of
high incidence mainly due to lack of awareness among both the local health policy makers …

Long-term event-free survival, chimerism and fertility outcomes in 234 patients with sickle-cell anemia younger than 30 years after myeloablative conditioning and …

F Bernaudin, JH Dalle, D Bories, RP de Latour… - …, 2019 - pmc.ncbi.nlm.nih.gov
Allogeneic stem cell transplantation remains the only curative treatment for sickle cell
anemia (SCA), but the place of myeloablative conditioning in the procedure remains to be …

[HTML][HTML] Management of sickle cell disease from childhood through adulthood

J Kanter, R Kruse-Jarres - Blood reviews, 2013 - Elsevier
Sickle cell disease (SCD) is a genetic disorder characterised by anaemia and “sickling” of
red blood cells, leading to chronic haemolytic anaemia, vascular injury, and organ …

Advances in the treatment of sickle cell disease

S Kapoor, JA Little, LH Pecker - Mayo Clinic Proceedings, 2018 - Elsevier
Sickle cell disease (SCD) is a monogenic disorder that afflicts approximately 100,000
Americans and millions of people worldwide. It is characterized by hemolytic anemia, vaso …

Survival among children and adults with sickle cell disease in Belgium: benefit from hydroxyurea treatment

PQ Lê, B Gulbis, L Dedeken, S Dupont… - Pediatric blood & …, 2015 - Wiley Online Library
Objective To evaluate the survival of patients with sickle cell disease (SCD) recorded in the
Belgian SCD Registry and to assess the impact of disease‐modifying treatments (DMT) …